Interfering with antiviral pathway may deter Alzheimer’s

Targeting part of a key antiviral pathway may one day offer a new therapeutic approach to deterring or delaying cognitive decline, according to preclinical research led by Weill Cornell Medicine scientists.

Knitted robotic textile promising for hand edema patients

Working with physicians at Weill Cornell Medicine and therapists at the Cayuga Medical Center, Cornell Hybrid Body Lab researchers have devised a knitted wearable technology that can ease discomfort caused by hand edema.

MacArthur Fellow to give Krieger Lecture on 19th-Century Black political organizing

May 2, MacArthur Fellow P. Gabrielle Foreman will give a talk, “Why Didn’t We Know?!: The Forgotten History of the Colored Conventions and 19th-Century Black Political Organizing,” on the history of 19th century Black activism.

Around Cornell

Klarman Fellow studies vocal learning in parrots

By studying the brain mechanisms of vocal learning in budgies, Zhilei Zhao explores how social learning is implemented in the brain.

Around Cornell

Tick races, teddy bear surgery: Veterinary Open House returns

After a three-year, pandemic-induced hiatus, the College of Veterinary Medicine resumed a beloved tradition and welcomed the community to its 54th Open House.

Professors’ documentary short wins award

The Award for Film and Video from the Society of Architectural Historians has been given to the film “We Love We Self Up Here.”

Around Cornell

Law team opposes South Carolina’s electric chair, firing squad

Faculty, students and alumni affiliated with Cornell Law School's Capital Punishment Clinic are leading a legal fight to prevent South Carolina from executing condemned prisoners by methods they argue are cruel and unusual.

Circumstances influence happiness as much as personality

Happiness can’t be bought, but nor does it depend mostly on one’s mindset, as many happiness surveys would suggest, according to a recent study by Cornell psychology researchers.

Trial shows strong COVID protection in antibody combination

A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial.